| http://www.w3.org/ns/prov#value | - Essentially any pharmaceutical carrier formulation suitable for topical application is within the scope of the present invention. [0023] Lysostaphin and lantibiotics such as nisin have been discovered to produce a synergistic effect when used in combination.
|
